July 3, 2012 | MUMBAI: Metformin has been the preferred and
widely-used first-line treatment medicine for Type 2 diabetes
for sometime now. In cases, where patients do not respond to
metformin, a new class of drugs (gliptins) are fast emerging as
a possible choice. The new drug, linagliptin, results in
significantly less weight gain than the most common second-line
treatments currently used, and may even carry a smaller risk of
cardiovascular events such as heart attack and stroke, according
to medical journal, The Lancet. January 11, 2013 | NEW DELHI:
India will soon revise its malaria mortality figures, with the
new estimates expected to be at least 20 times more than what
the health ministry portrays at present. A 16-member committee
of the Indian Council of Medical Research, headed by its former
director general Dr Padam Singh Pradhan, has found that the
actual number of malaria deaths in India on an average would be
around 40,297 â€" around 40 times higher than present estimates.
In a first such admissio